Risk Assessment of Metachronous Gastric Neoplasm after Endoscopic Resection for Early Gastric Cancer According to Age at Helicobacter pylori Eradication

Seunghan Lee,Soo-Jeong Cho,Hyunsoo Chung,Bokyung Kim,Mi Jin Oh,Yun Suk Na,Jun Hee Lee,Jiyoon Kim,Sang Gyun Kim
DOI: https://doi.org/10.5009/gnl230383
IF: 4.321
2024-03-21
Gut and Liver
Abstract:Background/Aims: <i>Helicobacter pylori</i> eradication can reduce the incidence of metachronous gastric neoplasm (MGN) after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). This study evaluated the risk of developing MGN after ESD for EGC based on age at <i>H. pylori</i> eradication.Methods: Data of patients who underwent curative ESD for EGC with <i>H. pylori</i> infection between 2005 and 2018 were retrospectively analyzed. The patients were allocated to four groups according to age at <i>H. pylori</i> eradication: group 1 (&lt;50 years), group 2 (50-59 years), group 3 (60-69 years), and group 4 (≥70 years).Results: All patients were followed up for at least 5 years after ESD. The 5-year cumulative incidence of MGN was 2.1%, 7.0%, 8.7%, and 16.7% in groups 1, 2, 3, and 4, respectively (p&lt;0.001), and groups 3 and 4 showed a significant increase in the risk of MGN (hazard ratio [HR], 4.66; 95% confidence interval [CI], 1.09 to 19.92 and HR, 10.75; 95% CI, 2.45 to 47.12). After adjustments for moderate to severe intestinal metaplasia based on the updated Sydney system, groups 3 and 4 remained significantly associated with MGN (HR, 4.40; 95% CI, 1.03 to 18.84 and HR, 10.14; 95% CI, 2.31 to 44.57).Conclusions: The incidence of MGN after ESD for EGC increased with age at <i>H. pylori</i> eradication. Age at <i>H. pylori</i> eradication ≥60 years was an independent risk factor for MGN, even after adjusting for the presence of advanced intestinal metaplasia.
gastroenterology & hepatology
What problem does this paper attempt to address?